FacebookInstagramTwitterYouTube
Call Toll Free (US Only): 1-800-980-STEM (7836)|From Outside or Inside US Call: 1-954-358-3382

UFC Champion TJ Dillashaw discusses how stem cell therapy in Panama cleared up his psoriasis

UFC bantamweight World Champion TJ Dillashaw discusses a side effect of his stem cell treatment at Stem Cell Institute in Panama with its founder, Neil Riordan, PA, PhD during dinner in Panama.

Dr. Riordan – I am talking about the last time you were down here.

TJ – I’ve been learning a lot about what the stem cell therapy did for me. Stuff that I didn’t even know it was going to do until I listened to you on the [Joe Rogan] podcast [with Mel Gibson]. And one was it got rid of my psoriasis.

Dr. Riordan – And where was your psoriasis?

TJ – My scalp. I had it for like six years. I thought changing my diet and all this stuff would help it out but I think what really helped it was coming down and getting stem cells.

Dr. Riordan – And how long was it after you got treated that you felt the difference?

TJ – Shoot. I didn’t notice for probably a couple months, I think is when I figured it out. I had it really bad but a couple months later it was completely gone.

Dr. Riordan – Wow.

TJ – I had it for six years, you know? Yeah.

2018-05-04T20:39:17+00:00 May 4th, 2018|Autoimmune Diseases, Autoimmune Diseases, mesenchymal stem cells, Neil Riordan Phd, News, Patient Stories, Patient Testimonials, Psoriasis, Psoriasis, Sports Injuries, Stem Cell Therapy, TJ Dillashaw, umbilical cord tissue stem cells, Video - Stem Cell Therapy|
Read More

Joe Rogan Interview with Mel Gibson and Dr. Riordan

Joe Rogan interviews Stem Cell Institute founder Neil Riordan, PA, PhD and award-winning actor, director and producer Mel Gibson, who first brought his father to Panama at the age of 92.  Mel discusses his father’s miraculous recovery.  He is now 99.  Dr. Riordan discusses stem cell therapy using human *umbilical cord-derived mesenchymal stem cells including their application in conditions like multiple sclerosis and autism.

*umbilical cords are donated following normal, healthy births

2018-04-03T21:36:32+00:00 April 3rd, 2018|Autism, Joe Rogan Podcast on YouTube, mesenchymal stem cells, multiple sclerosis, Neil Riordan, News, Riordan-McKenna Institute, spinal cord injury, Stem Cell Institute Panama, Stem Cell Therapy, umbilical cord tissue stem cells, Video - Stem Cell Therapy|
Read More

Video: Stem Cell Therapy in Panama with Dr. Riordan and Mel Gibson

Host Michael Beattie discusses stem cell therapy using *human umbilical cord tissue-derived mesenchymal stem cells (hUCT-MSCs)  at the Stem Cell Institute in Panama with renowned applied stem cell scientist and founder, Neil Riordan, Pa, PhD and acclaimed actor, director and producer Mel Gibson.

Dr. Riordan discusses the miraculous progress of a spinal cord injury patient and pilot whose doctors said that he would never walk again.  He talks about where the stem cells come from, how they work and why they can treat so many seemingly different conditions.  Dr. Riordan explains how umbilical cords, and subsequently, hUCT-MSCs used at the Stem Cell Institute are carefully selected using molecular screening.  He also discusses why mesenchymal stem cells from umbilical cords function better than MSCs from adults, especially as they age or if they are suffering from a disease like multiple sclerosis.  For example. MSCs from a newborn multiply exponentially compared to MSCs from an older adult.

Mel Gibson discusses his father’s miraculous recovery, literally from his deathbed after receiving hUCT-MSCs at the age of 92.  He’s currently 99 and still going strong having been treated in Panama several times since then.  Mel also discusses his personal experiences in Panama.

Watch all this and more.

*umbilical cord tissue harvested after normal, healthy births

2018-01-29T16:13:33+00:00 December 11th, 2017|Autism, Autism, Autoimmune Diseases, Cerebral Palsy, Heart Failure, Multiple Sclerosis, Multiple Sclerosis, Neil Riordan Phd, Neil Riordan PhD, News, Patient Testimonials, Spinal Cord Injury, Spinal Cord Injury, Stem Cell Institute Panama, Stem Cell Lecture Videos, Stem Cell Therapy, Video - Stem Cell Therapy|
Read More

Stem Cell Therapy at Stem Cell Institute on PBS-TV Dallas-Fort Worth this Sunday! PBS KERA TV-13

Brenda Watson Show. KERA
PBS TV (KERA 13) in Dallas-Fort Worth – Go inside our clinic and lab in Panama, and watch interviews with 3 patients. The other episode follows a knee patient through the treatment process at Dr. RIordan’s orthopedic stem cell clinic in Southlake, Texas. Sunday, January 29th from 12pm – 1pm.

Stem Cells I

Riordan-McKenna Institute – Stem Cell Therapy for Orthopedics

Take a journey with marathon runner and knee patient Jim Morella as he undergoes a stem cell augmented arthroscopic knee procedure. Peer inside the operating room as Dr. McKenna harvests stem cells from Jim’s bone marrow, prepares them, and injects them into his knee. Tag along with Brenda as she interviews Jim at home following his recovery.

Dr. McKenna discusses Jim’s case with Brenda and explains why stem cell injections alone are not necessarily the best solution to knee problems, including Jim’s. He also touches upon the FDA’s current role regarding regulations.

Dr. Riordan talks about how the proprietary amniotic membrane tissue product used by RMI can enhance bone marrow stem cell therapy and the safety aspects of such treatments.

Dr. McKenna Stem Cell Augmented Surgery 3

Stem Cells II

Stem Cell Institute in Panama: Spinal Cord Injury, Multiple Sclerosis (MS), Rheumatoid Arthritis (RA) and More…

Brenda Watson takes you inside the Stem Cell Institute and Medistem Labs in Panama. If you have ever wondered what stem cell therapy is like in Panama, this show is for you.

See inside the laboratory and clinic as Brenda follows three patients through the treatment and recovery process: Sam Harrell (MS), Juan Jose Ballareno (Spinal Cord Injury) and Todd Rinehart (RA).

Meet the team as she interviews key players:

Neil Riordan, PhD, Founder and Chief Scientist of Medistem Labs, explains how the Panamanian government regulates stem cells in Panama. He discusses how HUCT-MSCs work on RA before delving into the subject of clinical trials in Panama and the USA.

Medical director, Jorge Paz Rodriquez, MD discusses how HUCT-MSCs work and why they can be transplanted without immune system rejection.

Rodolfo Fernandez, Medistem Panama Laboratory Director talks about tissue selection and processing.

2017-01-25T17:16:08+00:00 January 25th, 2017|Bone Marrow Stem Cells, Dr. Wade McKenna, Medistem Labs Panama, mesenchymal stem cells, multiple sclerosis, Neil Riordan Phd, News, orthopedics, PBS TV Stem Cells, rheumatoid arthritis, Southlake, Stem Cell Institute Panama, Stem Cell Therapy PBS TV, Video - Stem Cell Therapy|
Read More

Arnold Caplan PhD from Case Western Reserve Visits Panama

Professor Arnold Caplan from Case Western Reserve with Dr. Riordan and friends during his recent trip to Panama. Dr. Caplan is known as the “Father of the Mesenchymal Stem Cell” although these days, he prefers the term “Medicinal Signaling Cells”.

Arnold Caplan in Panama 2016

View Dr. Caplan’s Video Lectures on Mesenchymal Stem Cells

2016-07-14T19:26:59+00:00 July 14th, 2016|Arnold Caplan PhD, mesenchymal stem cells, Neil Riordan Phd, News, Stem Cell Therapy|
Read More

Study Shows Bone Marrow Stem Cells Help Tennis Elbow

Tennis Elbow

A study published in the Jul-Dec 2014 edition of the Journal of Natural Science, Biology and Medicine entitled “Bone marrow injection: A novel treatment for tennis elbow“ concludes that a single injection of bone marrow aspirate concentrate (BMAC) into the elbow lead to significant improvement of patients suffering from tennis elbow.

The study followed 30 patients for 12 weeks and concluded that treatment of tennis elbow patients with single injection of BMA showed a significant improvement in short to medium term follow-up.

Perhaps more importantly, it concluded that, “In future, such growth factors and/or stem cells based injection therapy can be developed as an alternative conservative treatment for patients of tennis elbow, especially who have failed non-operative treatment before surgical intervention is taken.”

Fast forward to the present where at RMI, we are augmenting BMAC with *AlphaGEMS, a proprietary, pliable tissue allograft (transplant) derived from human placental amnion, which functions as a biologic structural matrix to facilitate and enhance tissue healing and repair. AlphaGEMS contains 108 different growth factors including WNT-4 and prostaglandin.

Prostaglandin inhibits inflammation, which occurs after injury and marks the beginning of the healing process. The faster we can tame this inflammation, the sooner the body can move on to the next phase of healing, regeneration. It’s important to note that AlphaGEMS has more than 60 times the amount of prostaglandin compared to other products.

WNT4 is arguably the single most important molecule required for wound healing. AlphaGEMS has more than 10 times the amount of WNT4 as competing products.

For more information about BMAC and AlphaGEMS at the Riordan-McKenna Institute Click Here.

If you are suffering from tennis elbow and would like to be evaluated for treatment, please start by completing our online medical history. Once we receive it, our staff will contact you to answer general questions and guide you through the rest of the application process, which usually includes a in-office evaluation with Dr. McKenna for local patients or a free telephone consultation for those who live further away.

Apply Today

About Tennis Elbow

Tennis elbow is an inflammation of the tendons that join the forearm muscles on the outside of the elbow. The forearm muscles and tendons become damaged from overuse — repeating the same motions again and again. This leads to pain and tenderness on the outside of the elbow. More on Tennis Elbow from AAOS.

About: Bone marrow injection: A novel treatment for tennis elbow

Abstract

Objective:

The objective of this prospective study was assessment of efficacy of bone marrow aspirate (BMA) (containing plasma rich in growth factors and mesenchymal stem cells) injection in treatment of tennis elbow.

Materials and Methods:

A total of 30 adult patients of previously untreated tennis elbow were administered single injection of BMA. This concentrate was made by centrifugation of iliac BMA at 2000 rpm for 20-30 min and only upper layer containing platelet rich plasma and mononuclear cells was injected. Assessment was performed at baseline, 2 weeks, 6 weeks and 12 weeks using Patient-rated Tennis Elbow Evaluation (PRTEE) score.

Results:

Baseline pre-injection mean PRTEE score was 72.8 ± 6.97 which decreased to a mean PRTEE score of 40.93 ± 5.94 after 2 weeks of injection which was highly significant (P < 0.0001). The mean PRTEE score at 6 week and 12 week follow-up was 24.46 ± 4.58 and 14.86 ± 3.48 respectively showing a highly significant decrease from baseline scores (P < 0.0001). Conclusion:

Treatment of tennis elbow patients with single injection of BMA showed a significant improvement in short to medium term follow-up. In future, such growth factors and/or stem cells based injection therapy can be developed as an alternative conservative treatment for patients of tennis elbow, especially who have failed non-operative treatment before surgical intervention is taken.



*Tissue used for AlphaGEMS is donated after normal, healthy births. Once it has been fully tested for infectious diseases, sterility and a few other things, the tissue is processed by using proprietary methods developed by Neil Riordan, PhD.

2015-10-20T20:00:27+00:00 October 20th, 2015|AlphaGEMS, Amniotic Membrane, Bone Marrow Stem Cells, Dallas-Forth Worth, Dr. Wade McKenna, Neil Riordan Phd, News, Riordan-McKenna Institute, Texas|
Read More

What are the sources of the stem cells used at Stem Cell Institute in Panama?

Lately, especially on our Facebook Page many people are asking us, “What is the source of the stem cells?”

Stem cells under fluorescent microscope.At the Stem Cell Institute, we use two types of stem cells. Primarily, we use allogeneic mesenchymal stem cells harvested from human umbilical cord tissue. In addition to allogeneic mesenchymal stem cells, our spinal cord injury protocol uses autologous (patient’s own) stem cells harvested from bone marrow.

Umbilical cord tissue is donated by mothers after normal, healthy births.

All donating mothers are tested for infectious diseases and have their medical histories screened. We obtain proper consent from each family prior to umbilical cord donation.

All mesenchymal stem cells harvested from umbilical cords are screened for infectious diseases to International Blood Bank Standards before they are approved for use in treatments.

A small number of umbilical cords (about 1 in 10) pass our rigorous screening process.

Dr. Riordan on the Umbilical Cord Selection Process at Stem Cell Institute

“Through retrospective analysis of our cases, we’ve identified proteins and genes that allow us to screen several hundred umbilical cord donations to find the ones that we know are most effective. We only use these cells and we call them ‘golden cells’.

We go through a very high throughput screening process to find cells that we know have the best anti-inflammatory activity, the best immune modulating capacity, and the best ability to stimulate regeneration.”

What are the advantages of treating with allogeneic human umbilical cord tissue (HUCT)-derived mesenchymal stem cells?

  • Anyone can be treated since HUCT mesenchymal stem cells are immune system privileged. Human Leukocyte Antigen (HLA) matching is not necessary.
  • The stem cells with the best anti-inflammatory activity, immune modulating capacity, and ability to stimulate regeneration can be screened and selected.
  • Allogeneic stem cells can be administered multiple times over the course of days in uniform dosages that contain high cell counts.
  • Umbilical cord tissue provides an abundant supply of mesenchymal stem cells.
  • No need to collect stem cells through invasive procedures such as liposuction or bone marrow collection
  • There is a growing body of evidence showing that mesenchymal stem cells from umbilical cords are more robust than mesenchymal stem cells from other sources such as fat.

The body’s immune system is unable to recognize human umbilical cord tissue (HUCT)-derived mesenchmyal stem cells as foreign and therefore they are not rejected. HUCT stem cells have been administered thousands of times at the Stem Cell Institute and there has never been a single instance rejection (graft vs. host disease). Umbilical cord-derived mesenchymal stem cells also proliferate/differentiate more efficiently than “older” cells, such as those found in the fat and therefore, they are considered to be more “potent”.

Watch Professor Arnold Caplan from Case Western Reserve University explain how this works.

2015-09-25T17:52:15+00:00 September 25th, 2015|Bone Marrow, Mesenchymal Stem Cells, News, Parkinson's, Stem Cell Institute Panama, Stem Cell Therapy, Stem Cells, Umbilical cord tissue|
Read More

MS patient’s quality of life improvement “unbelievable” after stem cell therapy

Cathy Duke's Testimonial - with comment

“Thank you everyone for your kind words. Stem cells did not cure my MS, but they have improved my quality of life so much it is unbelievable. I have always had the support of my family and friends, and for this, I have been VERY appreciative. Stem cell therapy has given me a new quality of life and I thank God, my family and Dr. Neil Riordan at the Stem Cell Institute in Panama City, Panama. Life is good :-)” – Cathy Miller Duke

“Last year on this day, my mom wasn’t able to participate in the Mackinac Bridge walk because, at exactly this time, she was in Panama receiving stem cell therapy, hoping it would improve her quality of life. Today, she was able to participate and walk that bridge…without a cane. (And apparently, she walked backwards a little jogged some too!) So proud of you mom!” – Michelle Duke Thompson

2015-09-14T20:13:47+00:00 September 14th, 2015|Multiple Sclerosis, Multiple Sclerosis, multiple sclerosis, Neil Riordan Phd, News, Patient Stories, Stem Cell Institute Panama, Stem Cell Therapy|
Read More

PRESS RELEASE – Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound

Dallas-Fort Worth (PRWEB) August 28, 2015 – Riordan-McKenna Institute founders, stem cell expert Neil Riordan, PhD and orthopedic surgeon, Wade McKenna, DO, announced today that the use of sterile, dehydrated amniotic tissue AlphaPATCH™ developed by Amniotic Therapies in Dallas, Texas, resulted in complete healing of an otherwise non-healing surgical knee wound.

Before-After.262x175The case involved a 78-year-old male, who presented with a non-healing surgical wound following a right total knee replacement performed six weeks prior. The patient had not responded after 6 weeks of conservative wound care and the wound showed no signs of healing.

Dr. McKenna irrigated the wound in the operating room under pulse lavage and then placed two AlphaPATCH dry amniotic membranes (4 cm x 4 cm) over the wound before dressing it.

At the two-week follow-up visit, a central scab had formed. At four-weeks, the wound had completely scabbed over. At eight-weeks the scab had just fallen off and the wound was healing well with immature skin representing the size of a penny. At the ten-week follow-up visit, the wound was completely healed.

The case report, entitled “Case Report Of Non-Healing Surgical Wound Treated With Dehydrated Amniotic Membrane” is published in the July issue of the Journal of Translational Medicine. Authors include Dr. Riordan, Dr. McKenna, Troy Chandler, PA-C, and Ben George, PA-C. This milestone in Dr. Riordan and Dr. McKenna’s ongoing study of biologic wound healing using amniotic tissue products and stem cells is the third peer reviewed journal article on regenerative medicine published by the Riordan McKenna Institute.

A common misconception is that dehydrated amniotic membrane products like AlphaPATCH contain live stem cells. Although dehydrated amniotic membrane does not contain any stem cells, it does contain a number of growth factors that promote healing and stimulate the body’s own stem cells to become activated and likely behave more similar to stem cells in a younger person.

“It’s gratifying to have this new tool in my toolbox. I treated conservatively and was getting nowhere. Even in a patient with a significant smoking history and decreased blood flow to his legs, we were able to achieve this result. Chronic wounds can be very frustrating for both the patient and the caregiver,” remarked Troy Chandler, PA-C, who participated in the patient’s treatment.

About Riordan-McKenna Institute (RMI)

RMI specializes in non-surgical treatment of acute and chronic orthopedic conditions using *AlphaGEMS flowable amniotic tissue allograft and bone marrow aspirate concentrate (BMAC) that is harvested using the patented BioMAC bone marrow aspiration cannula. Common conditions treated include meniscal tears, ACL injuries, rotator cuff injuries, runner’s knee, tennis elbow, and joint pain due to degenerative conditions like osteoarthritis. RMI also uses AlphaPATCH amniotic membranes as part of a complete wound care treatment regimen.

RMI also augments orthopedic surgeries with BMAC and AlphaGEMS to promote better post-surgical outcomes.

BMAC contains a patient’s own mesenchymal stem cells (MSC,) hematopoietic stem cells (CD34+), growth factors and other progenitor cells. AlphaGEMS is composed of collagens and other structural proteins, which provide a biologic matrix that supports angiogenesis, tissue growth and new collagen during tissue regeneration and repair.

*AlphaGEMS and AlphaPATCH products are produced by Amniotic Therapies Inc. from donated amniotic tissue after normal healthy births. For more information about AlphaGEMS, please visit: http://www.rmiclinic.com/non-surgical-stem-cell-injections-joint-pain/stemnexa-protocol/

www.rmiclinic.com

801 E. Southlake Blvd.
Southlake, Texas
76092

Tel: (817) 776-8155
Toll Free: (877) 899-7836
Fax: (817) 776-8154

About Amniotic Therapies

Based in Dallas, Texas, Amniotic Therapies specializes in the processing and distribution of human amniotic tissue products for the biologic and regenerative medicine segments of the healthcare market. Amniotic Therapies’ mission is to provide superior human amniotic tissue products that naturally enhance the body’s healing ability, providing patients with improved healing.

Amniotic Therapies is registered with the U.S. Food and Drug Administration (FDA) and is in the process of receiving accreditation from the American Association of Tissue Banks.

www.amniotictherapies.com

11496 Luna Rd. Suite 800
Dallas, Texas
75235

Tel: (972) 465-0496

2015-08-28T19:15:27+00:00 August 28th, 2015|Amniotic Membrane, Amniotic Therapies, Dallas-Forth Worth, Neil Riordan Phd, News, Riordan-McKenna Institute, Southlake|
Read More